The Horowitz Family Supports The Battle Against Infectious Diseases at Rabin Medical Center

A generous donation by the Eli and Dalia Horowitz Family Fund to Israel’s Rabin Medical Center will support a three component program in Infectious Diseases including:

  1. An artificial intelligence system for choosing the correct antibiotics at a very early stage of the infection (TREAT).
  2. A project focusing on reducing and preventing infections at hospitals
  3. A campaign to raise awareness for infectious diseases.

In the first stage of the artificial intelligence system mentioned above, a new innovative computerized system has been integrated at the Rabin Medical Center. The TREAT system has already proven its advantages through a vital experiment eight years ago at Rabin Medical Center and at premier medical institutions in Europe. The system effectively combines data of the infected patient with the probable data of the infections surrounding the patient to produce an educated recommendation of the suggested antibiotic treatment.

This system is vital for proper treatment of infection and is a response to the report of Israel‘s state comptroller from May 2013 warning that 4,000-6,000 people die in Israel each year from severe infections contaminated in hospitals. The same report also said that 1,000-4,500 of these deaths could have been prevented.

Related Articles

Rabin Medical Center Participates in Emergency Exercises


It was perhaps ironic that on the day that a special emergency exercise in the event of a chemical attack in a central neighborhood was held at Rabin Medical Center a real rocket fell in Beer Sheva showing the importance of always being prepared.


read more »

Stem Cell Technology is Here


Over the weekend of December 2, 2005, more than 500 people had an opportunity to learn of revolutionary practices at Rabin Medical Center.


read more »

New Research From Rabin Medical Center May Lead to Cure for Melanoma


A group of researchers from Tel Aviv University has discovered how malignant tumors from melanoma, the deadly skin cancer, work. The group is led by a young lecturer and researcher, Dr. Carmit Levy.


read more »